Merck's new anabolic steroid: MK-0773 (J Biol Chem. 2010 May 28; 285 (22): 17054-64.)
He doesn't have a real name yet, but if it is up to the important men of Merck / Schering-Plow Pharma , then it will be on the market in the near future: the anabolic steroid MK-0773. You can see his...
For a long time, S-4 or Andarine was believed to be the answer that researchers had long been seeking.
The perfect selective androgen receptor modulator that could prevent muscle wasting and reduce the risk of benign prostatic hyperplasia.
Phase-I Human clinical trials happened. The results...
anavar
andarine
back
bodybuilder
bodybuilders
bodybuilding
called
chemical
fact
gtx
long
mk-2866
muscle
ostarine
potential
research
s-4
sarm
sarms
test
testosterone
therapeutic
wada
GTx Presents Phase II Ostarine (MK-2866) Cancer Cachexia Clinical Trial Results at Endocrine Society Annual MeetingOstarine Improved Lean Body Mass and Muscle Performance in Patients with Cancer CachexiaWASHINGTON, June 11, 2009 - (Business Wire) - GTx, Inc. (Nasdaq: GTXI - News) today announced...
baseline
body
cachexia
cancer
climb
clinical
gtx
lbm
lean
loss
mass
mk-2866
muscle
ostarine
patients
phase
placebo
results
significant
statistically
study
subject
test
treatment
trial
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.